- $34.59bn
- $34.33bn
- $4.69bn
- 99
- 25
- 93
- 85
Annual balance sheet for Resmed, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 463 | 295 | 274 | 228 | 238 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 484 | 625 | 602 | 736 | 875 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1,523 | 1,575 | 1,931 | 2,368 | 2,358 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 536 | 592 | 630 | 666 | 699 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 4,587 | 4,728 | 5,096 | 6,752 | 6,872 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 603 | 912 | 689 | 759 | 911 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 2,090 | 1,842 | 1,735 | 2,622 | 2,008 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 2,497 | 2,886 | 3,361 | 4,130 | 4,864 |
Total Liabilities & Shareholders' Equity | 4,587 | 4,728 | 5,096 | 6,752 | 6,872 |
Total Common Shares Outstanding |